Homocysteine Metabolism in Children with Down Syndrome: In Vitro Modulation

This publication has 38 references indexed in Scilit:

• Pathogenesis of mental deficiency in trisomy 21
  American Journal of Medical Genetics, 2005
• A Sensitive New Method for Rapid Detection of Abnormal Methylation Patterns in Global DNA and within CpG Islands
  Biochemical and Biophysical Research Communications, 1999
• Evidence against the Current Hypothesis of “Gene Dosage Effects” of Trisomy 21: ets-2, Encoded on Chromosome 21” Is Not Overexpressed in Hearts of Patients with Down Syndrome
  Biochemical and Biophysical Research Communications, 1999
• Down’s syndrome, ageing and fragile sites
  Mechanisms of Ageing and Development, 1998
• Down Syndrome and Celiac Disease
  Journal of Pediatric Gastroenterology and Nutrition, 1995
• In vivo folic acid supplementation partially corrects in vitro methotrexate toxicity in patients with Down syndrome
  British Journal of Haematology, 1995
• Alzheimer's disease and down syndrome: leukocyte membrane fluidity alterations
  Mechanisms of Ageing and Development, 1994
• IS ABSENCE OF ATHEROMA IN DOWN SYNDROME DUE TO DECREASED HOMOCYSTEINE LEVELS?
  The Lancet, 1988
• Levels of some purine metabolizing enzymes in lymphocytes from patients with Down's syndrome
  Biochemical Medicine and Metabolic Biology, 1986
• Homocystinuria — The Effects of Betaine in the Treatment of Patients Not Responsive to Pyridoxine
  New England Journal of Medicine, 1983